25 LLC’s Usana Health Sciences USNA Stock Holding History

25 LLC’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16	Closed	-$983	–	539
2023 Q2	$983	Buy	16 +8	+100%	+$509	﹤0.01%	297
2023 Q1	$532	Buy	+8	New	+$477	﹤0.01%	320

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

25 LLC's USNA Position: Q3 2023 in Review

25 LLC sold out of Usana Health Sciences (USNA) in Q3 2023, closing a stake of 16 shares — an estimated $983 sold.

25 LLC first reported a position in USNA in Q1 2023 and held it in 2 quarters. The position peaked at $983 in Q2 2023. 160 funds tracked by Wall St. Rank hold USNA as of Q3 2023.

25 LLC reported no remaining Usana Health Sciences position as of Q3 2023 after selling out during the quarter.
25 LLC sold 16 Usana Health Sciences shares in Q3 2023, an estimated $983.
25 LLC first reported a position in Usana Health Sciences in Q1 2023 and held it in 2 quarters.
25 LLC's Usana Health Sciences position peaked at $983 in Q2 2023.
160 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.